Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Nov 10, 2025, after the close
10-Q filed Nov 10, 2025, 41 days after period end · 0001193125-25-274262
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$2.87M | -$3.49M | -$3.60M | -$3.99M |
| EPS Diluted | -$0.38 |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$2.32 |
| -$7.38 |
| -$4.10 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
